-
The national landscape of kidney transplantation for undocumented immigrants: advancing kidney transplantation equity. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Katherine Rizzolo,Leonela Villegas,Lilia CervantesAlthough undocumented people are eligible for kidney transplant from a regulatory standpoint, undocumented individuals are often excluded from federal health insurance, leading to difficulty accessing kidney transplant. Menon et al. highlight lower mortality and graft failure rates for presumed undocumented immigrants compared with residents and citizens post-transplant. In this commentary, we emphasize
-
Osteocytes burn out, give bone a break. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Aline MartinThe pathogenic mechanisms of chronic kidney disease-induced osteoporosis are not well understood and might involve metabolic alterations and apoptosis of osteocytes. In this issue, Hsu et al. present experimental work in uremic mice and cultured mouse osteoblasts showing that impaired mitochondrial function and mitophagy in osteocytes contribute to chronic kidney disease-associated osteoporosis. They
-
Executive summary for the China Kidney Disease Network (CK-NET) 2017-2018 Annual Data Report. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Chao Yang,Bixia Gao,Fang Wang,Hong Chu,Jinwei Wang,Xiaoyu Sun,Ping Zhang,Hui Xu,Huijuan Mao,Changying Xing,Menghua Chen,Li Zuo,Yue Wang,Feng Yu,Hong Zhang,Haibo Wang,Jianghua Chen,Luxia Zhang,Ming-Hui Zhao,Chronic kidney disease (CKD) has become a public health issue. Rapid urbanization in China has been intimately linked to shifts in the spectrum of CKD, particularly as regards CKD related to diabetes mellitus. By amalgamating diverse data streams and harnessing cutting-edge technologies, the China Kidney Disease Network aspires to evolve into a comprehensive surveillance framework for kidney diseases
-
SGLT2 inhibitors fulfill their expectations in diabetic kidney transplant recipients. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Elisabet Van Loon,Pieter Gillard,Maarten Naesens -
Medical care of acute kidney injury in limited resource settings: a call to action. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Yasser M Abdelhamid,Amel Harzallah,Vincent Boima,Bala Waziri,Niakhaleen Keita, -
Corrigendum to "Effects of dialysate potassium concentration of 3.0 mmol/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia." Kidney International 2025;107:169-179. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
David M Charytan,Wolfgang C Winkelmayer,Christopher B Granger,John P Middleton,Charles A Herzog,Glenn M Chertow,James M Eudicone,Jeremy D Whitson,James A Tumlin, -
The Standardized Outcomes in Nephrology (SONG) initiative: a decade of harmonizing patient voices and research in kidney disease. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Colm O'Reilly,Jonathan C Craig,Younghee Cho,Sally Crowe,John S Gill,Brenda Hemmelgarn,Martin Howell,Anastasia Hughes,Angela Ju,Karine Manera,Braden Manns,Roberto Pecoits-Filho,Benedicte Sautenet,Nicole Scholes-Robertson,Armando Teixeira-Pinto,Peter Tugwell,Wim Van Biesen,Andrea K Viecelli,Angela Yee-Moon Wang,Wolfgang C Winkelmayer,Germaine Wong,Chandana Guha,Allison Jaure -
Effective management of chyluria with retrograde thoracic duct catheterization and embolization. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Matthias Barral,Lionel Arrivé,Armance Marchal,Raphael Dautry -
"Conclusions from a KDIGO Controversies Conference" and CKD-MBD-associated osteoporosis. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Michael Pazianas,Paul D Miller -
The Case | A 67-year-old woman with peripheral neuropathy and nephrotic syndrome. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Charankumar Swamikannu,Mookiah Seenivasan,Jayalakshmi Seshadri,Anila Abraham Kurien -
Osmotic nephropathy induced by SGLT2 inhibitor overdose. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Yoshihiro Kawata,Makoto Araki,Yasuhiro Onodera,Yayoi Ogawa,Mitsuru Yanai -
Kidney transplantation and hyperbaric oxygen treatment for calciphylaxis. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Espen Nordheim,Markus Hovd,Dag Olav Dahle -
Expanding the perspective: addressing additional limitations in cardiovascular risk assessment of immunosuppressive therapies. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Mian Wei,Yun Liu,Jianhua Zhu -
How frequent is frequent? Rethinking monitoring intervals in glomerular disease. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Mohamed E Elrggal -
Heartfelt concerns: the overlooked cardiac risks in glomerular disease management. Kidney Int. (IF 14.8) Pub Date : 2025-06-01
Jiachuan Xiong,Jinghong Zhao -
A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients. Kidney Int. (IF 14.8) Pub Date : 2025-05-22
William R Mulley,Dhakshayini Tharmaraj,Kevan R Polkinghorne,Greg H Tesch,Sukhpal K Dayan,Edward Kwan,Moshe Olshansky,Tia Mark,Darren Lee,Peter F Mount,Germaine Wong,Kate R Wyburn,Wai H Lim,Peter G Kerr,David J Nikolic-Paterson,John KanellisINTRODUCTION Chronic active antibody-mediated rejection (AMR) is the leading cause of death-censored kidney allograft loss, with no proven treatments. While intravenous immunoglobulin (IVIG) has been used in certain cases, its efficacy is unknown. METHODS In this open-label multicenter randomized controlled trial (VIPAR), participants with biopsy-proven chronic active AMR, were assigned to six doses
-
Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models. Kidney Int. (IF 14.8) Pub Date : 2025-05-21
Eliza Bollinger,George Williams,Mary E Piper,Kimberly Steen,Kelly Tam Neale,Xian Chen,Mackenzie Marshall,Srinath Jagarlapudi,Yasaman Jami-Alahmadi,Pierre M Jean-Beltran,LouJin Song,Joshua Chiou,Frank Geoly,Sarah R Vargas,Ying Zhang,Elaine Kuang,Daniel Callahan,John C Stansfield,Max Russo,John Griffin,Zhongyuan Sun,Melissa R Miller,Craig L Hyde,Michelle F Clasquin,Katherine Hales,Natalie A Daurio,JustinINTRODUCTION Patients with metabolic syndrome and heart failure (HF) often have accompanying kidney dysfunction, which was recently defined as cardiovascular-kidney-metabolic (CKM) syndrome. Prior metabolomics profiling of metabolic syndrome patients identified a plasma branched chain amino acid (BCAA) signature, and BCAAs themselves are elevated in the myocardium of patients with HF, potentially due
-
Clinical relevance of computationally derived tubular features and their spatial relationships with the interstitial microenvironment in minimal change disease/focal segmental glomerulosclerosis. Kidney Int. (IF 14.8) Pub Date : 2025-05-21
Fan Fan,Qian Liu,Jarcy Zee,Takaya Ozeki,Dawit Demeke,Yingbao Yang,Markus Bitzer,Christopher L O'Connor,Alton B Farris,Bangcheng Wang,Manav Shah,Jackson Jacobs,Laura Mariani,Kyle Lafata,Jeremy Rubin,Yijiang Chen,Lawrence Holzman,Jeffrey B Hodgin,Anant Madabhushi,Laura Barisoni,Andrew JanowczykBACKGROUND Visual scoring of tubular damage has limitations in capturing the full spectrum of structural changes and prognostic potential. Here, we investigated if computationally quantified tubular features can enhance prognostication and reveal spatial relationships with interstitial fibrosis. METHODS Deep-learning and image-analysis approaches were employed on 254/266 Periodic acid Schiff-stained
-
The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy. Kidney Int. (IF 14.8) Pub Date : 2025-05-20
Nattawat Klomjit,Michael D Evans,Maria Vargas,Nicholas Marka,Fernando Fervenza,Sanjeev Sethi,Ladan ZandINTRODUCTION Monoclonal gammopathy of renal significance (MGRS) is increasingly recognized as an important causes of kidney failure. A kidney biopsy remains an important diagnostic measure. However, a kidney biopsy is not without risks. Here, we devised the Mayo MGRS Prediction Tool to assess the probability of finding MGRS in patients with chronic kidney disease with monoclonal gammopathy (MG). METHODS
-
From Niche to Norm: A Multi-Action Plan to Close Gaps and Mainstream Incremental Hemodialysis. Kidney Int. (IF 14.8) Pub Date : 2025-05-20
Mariana Murea,Massimo Torreggiani,Javier Deira,Tammy L Sirich,Andrea K Viecelli,Enric Vilar,Miguel Á Suárez-Santisteban,John T Daugirdas,Ken Farrington,Kamyar Kalantar-Zadeh,Patrick Saudan,David A Jaques,Kristie L Foley,Ucheoma C Nwaozuru,Andrew Davenport,Elizabeth J Lindley,James Tattersall,Carlo Basile,Francesco G Casino,Giorgina B PiccoliAttention is increasingly turning toward the individualization of hemodialysis prescriptions through an incremental start. This approach prioritizes patient's clinical needs over rigid metrics like dialysis urea depuration, begins with fewer sessions (one or two per week), and gradually increases in frequency and/or duration based on patient's evolving clinical condition. Clinical manifestations related
-
The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of TET2/NLRP3 inflammasome signaling pathway. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Mingwei Fu,Zirong Lan,Yuanzhi Ye,Yuan Gong,Qingchun Liang,Mingxi Li,Liyun Feng,An Chen,Qianqian Dong,Yining Li,Siyi Wang,Xiaoyu Liu,Xiuli Zhang,Jing-Song Ou,Lihe Lu,Jianyun YanINTRODUCTION Vascular calcification is prevalent in chronic kidney disease (CKD), but existing medical treatments fail to achieve satisfactory therapeutic effects. Vascular calcification is now recognized as an active multifactorial process involving diverse mechanisms. Alpha-ketoglutarate (AKG), an intermediate in tricarboxylic acid cycle, has been demonstrated to extend lifespan and ameliorate age-related
-
Expanding the spectrum of genetic causes of DNA-specific exonucleaseTREX1 variants in thrombotic microangiopathy Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Zhuo-ran Song, Zhi-ying Liu, Meng-shi Li, Yang Li, Jing-yi Li, Ji-Cheng Lv, Hong Zhang, Xu-jie ZhouThrombotic microangiopathy (TMA) is a complex condition involving endothelial damage and microvascular thrombi. The International Society of Nephrology’s HUS International Forum identified genetic variants as crucial for tailored therapies like plasma exchange and anti-complement therapy. Recent studies suggested that new pathogenic genes beyond complement, and coagulation pathways contribute to TMA
-
A nationwide register-based cohort study examined the association between preeclampsia in mothers and the risk of kidney disease in their offspring. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Ida Lihme,Saima Basit,Frederikke Lihme,Mette B Damholt,Sarah Hjorth,Ellen A Nohr,Heather A BoydINTRODUCTION Women with preeclampsia often deliver preterm (under37 weeks gestation). Preterm birth is associated with an increased risk of offspring kidney disease, but whether preeclampsia is independently associated with kidney disease risk is unknown. Here, we conducted a register-based cohort study to explore associations between maternal preeclampsia and offspring kidney disease after accounting
-
Anti-nephrin antibodies guide living donor kidney transplantation in a pediatric patient with primary focal segmental glomerular sclerosis. Kidney Int. (IF 14.8) Pub Date : 2025-05-16
Sandra Habbig,Hanna Debiec,Malha Chedik,Dirk L Stippel,Florian Erger,Alexia Lourenço,Max C Liebau,Pierre RoncoINTRODUCTION Disease recurrence after kidney transplantation (KTx) remains a major challenge in patients with primary focal segmental glomerulosclerosis (pFSGS). Antibodies targeting the slit diaphragm protein nephrin have been identified in patients with early disease recurrence. Here, we describe monitoring and effective pre-transplant elimination of anti-nephrin antibodies in an adolescent with
-
Metabolic dysfunction–associated kidney disease: pathogenesis and clinical manifestations Kidney Int. (IF 14.8) Pub Date : 2025-05-14
Anip Bansal, Michel ChoncholIn recent years, there have been significant changes in the lifestyle and dietary habits of the population characterized by an increased intake of high-calorie food and a sedentary lifestyle without physical activity. The increased prevalence of overweight and obesity has led to metabolic dysfunction and related complications, such as cardiovascular disease and chronic kidney disease. The purpose of
-
Regulation of podocyte surface proteins by the enzyme A Disintegrin And Metalloproteinase 10 (ADAM10) Kidney Int. (IF 14.8) Pub Date : 2025-05-06
David Rosenbaum, Julia Reichelt, Simonas Gudaitis, Stine Kühne, Stephanie Zielinski, Desiree Loreth, Lukas Blume, Johannes Brand, Helga Vitzthum, Wiebke Sachs, Alina Lampert, Lisa Seipold, Matthias Voss, Catherine Meyer-Schwesinger, Paul SaftigPodocytes are terminally differentiated cells of the kidney filtration barrier. Their network of interdigitating foot processes embraces the glomerular capillaries and are likely remodeled by cleavage of podocyte surface proteins. The metalloproteinase ADAM10 is a major regulator of such surface protein shedding and was recently implicated in the pathophysiology of antibody-mediated podocyte injury
-
Unexpected effect of dexamethasone on acute kidney injury. Kidney Int. (IF 14.8) Pub Date : 2025-05-06
Reiko Inoue,Hiroshi Nishi -
Transgenic human nephrin in Drosophila nephrocytes facilitates variant analysis Kidney Int. (IF 14.8) Pub Date : 2025-04-30
Julia Melina Wolff, Konrad Lang, Mengmeng Chen, Julian Milosavljevic, Séverine Kayser, Martin Helmstädter, Gerd Walz, Ahmed Abed, Lea Gerstner, Sami Bahar, Maximilian H. Ulbrich, Tobias HermleNephrin, the key structural protein of the slit diaphragm, is encoded by NPHS1. Pathogenic variants in this gene are the primary cause of congenital nephrotic syndrome. About 400 variants have been described but functional characterization in vitro is very limited.
-
ILC1s drive tissue-aggressive macrophages in experimental lupus nephritis. Kidney Int. (IF 14.8) Pub Date : 2025-04-28
Lennard Ostendorf,Deepak A Rao -
Unlocking the full potential of human pluripotent stem cell–derived kidney organoids through bioengineering Kidney Int. (IF 14.8) Pub Date : 2025-04-23
Iphigénie Goux Corredera, Gaia Amato, Daniel Moya-Rull, Elena Garreta, Nuria MontserratHuman pluripotent stem cells hold inherent properties, allowing researchers to recapitulate key morphogenetic processes. These characteristics, coupled with bioengineering techniques, have led to the definition of early procedures to derive organ-like cell cultures, the so-called organoids. With regard to kidney organoids, challenges stand ahead, such as the need to enhance cellular composition, maturation
-
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy–associated kidney lesions Kidney Int. (IF 14.8) Pub Date : 2025-04-23
Samih H. Nasr, Virginie Royal, Alejandro Best Rocha, Maike Büttner-Herold, Candice Roufosse, Frank Bridoux, Wesam Ismail, Lihong Bu, Lynn D. Cornell, Amélie Dendooven, Rajib K. Gupta, Shigeo Hara, Vincent Javaugue, Nicolas Kozakowski, Satoru Kudose, Gonzalo P. Méndez, Kimberley Oliver, Maria M. Picken, Dominick Santoriello, Sanjeev Sethi, Akira Shimizu, Geetika Singh, M. Barry Stokes, Su-xia Wang,The spectrum of kidney lesions associated with monoclonal gammopathy has significantly expanded over the past 2 decades, with description of new entities and variants of old entities. Pathologic diagnosis is challenging because of lesional complexity, heterogeneity, and reliance on electron microscopy and ancillary techniques. A lack of precise pathologic definitions and uniform terminology has hampered
-
KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children. Kidney Int. (IF 14.8) Pub Date : 2025-05-01
,Jürgen Floege,Keisha L Gibson,Marina Vivarelli,Adrian Liew,Jai Radhakrishnan,Brad H Rovin -
Gene signature-guided drug screening identified narciclasine as a potential therapeutic for interstitial fibrosis of the kidney Kidney Int. (IF 14.8) Pub Date : 2025-04-22
An Xiao, Xiaoer Chen, Jingyi Ma, Xiaomei Chen, Tantan Long, Yuanyuan Ma, Qingzhou Chen, Zhiyuan Su, Zheng Hu, Liling Xie, Lei Zhang, Fengxin Zhu, Jing NieChronic Kidney Disease (CKD) is marked by progressive tubulointerstitial fibrosis (TIF), a pathological feature insufficiently addressed by existing therapies.
-
B cell–derived exosomal miR-483-5p and its potential role in promoting kidney function loss in IgA nephropathy Kidney Int. (IF 14.8) Pub Date : 2025-04-22
Izabella Z.A. Pawluczyk, Jasraj S. Bhachu, Jeremy R. Brown, Michael Lacey, Chidimma Mbadugha, Kees Straatman, David Wimbury, Haresh Selvaskandan, Jonathan BarrattWhile mesangial IgA deposition is the pathognomonic feature of IgA nephropathy (IgAN), the extent of mesangial IgA accumulation does not correlate with the future risk of kidney failure. This has led to the search for other serum factors that may influence clinical outcome. The emergence of microRNAs (miRs) as negative regulators of gene expression and the increasingly recognized role of extracellular
-
Analysis of the prespecified FIDELITY pooled patient dataset examined the efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate Kidney Int. (IF 14.8) Pub Date : 2025-04-21
Sankar D. Navaneethan, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luis M. Ruilope, Phyllis August, Meike Brinker, Andrea Lage, Luke Roberts, Charlie Scott, Pantelis Sarafidis, FIDELIO-DKD and FIGARO-DKD InvestigatorsThe efficacy and safety of finerenone (a nonsteroidal mineralocorticoid receptor antagonist) versus placebo were assessed according to different changes in estimated glomerular filtration rate (eGFR) using data from FIDELITY, a pooled individual-level analysis of two clinical trials.
-
CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis Kidney Int. (IF 14.8) Pub Date : 2025-04-21
Uwe Jerke, Claudia Eulenberg-Gustavus, Dimitrios Laurin Wagner, Adrian Schreiber, Ralph KettritzProteinase 3 (PR3) is a major autoantigen in patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). Here, we performed a proof-of-principle study using ex vivo CRISPR-Cas9 guided gene editing to eliminate the PR3 autoantigen as an alternative to suppressing the autoimmune response to PR3.
-
Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity Kidney Int. (IF 14.8) Pub Date : 2025-04-21
Hengcheng Zhang, Gianmarco Sabiu, Sungwook Jung, Manuel A. Podestà, Jing Zhao, Maya Gempler, Minako Yamamura, Jinxu Miao, George C. Tsokos, Ahmad Karadagi, Tatsuo Kawai, Reza Abdi, Peter T. SageAntibody-mediated rejection (ABMR) after allogeneic kidney transplantation is a substantial clinical problem for which there are no specific treatments. High endothelial venules (HEV) are specialized veins which are normally present only in lymph nodes (LN) facilitating immune cell entry. Here, we show that kidneys undergoing rejection develop HEV-like structures derived from host cells.
-
Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition Kidney Int. (IF 14.8) Pub Date : 2025-04-21
Fugang Li, Qigang Lan, Yaqin Wang, Jiachuan Xiong, Tangli Xiao, Shuiqin Gong, Yan Li, Shaobo Wang, Mengying Yao, Liangjing Lv, Shaozong Qin, Wang Xin, Li Liu, Bo Zhang, Jinghong ZhaoProximal tubular epithelial cells with different DNA contents emerge after acute kidney injury (AKI). However, their heterogeneity and roles in the acute kidney injury-to-chronic kidney disease (AKI-to-CKD) transition remain incompletely understood.
-
-
-
-
-
-
-
The authors reply Kidney Int. (IF 14.8) Pub Date : 2025-04-18
An S. De Vriese, Sanjeev Sethi, Fernando C. Fervenza -
-
Fluoroscopic repositioning of Tenckhoff catheter Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Kai Ming Chow, Gordon Chun-Kau Chan, Terence Pok-Siu Yip -
Thrombotic microangiopathy following scorpion envenomation Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Anila Abraham Kurien, Praveen Revu -
Renal involvement in aceruloplasminemia Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Tong Wu, Shicong Yang, Qiong Wen, Xin Bi, Xiaotao Hou, Wei Chen, Wenfang Chen -
The Case | A patient with multiple myeloma, heart failure, and nonresolving acute kidney injury Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Míriam Montero-Estopiñá, Desirée Catalán-García, Eduardo Cortés, Valentina M. Blanco-Fernández, Jordi Soler-Majoral, Gladys Ibarra Fernandez, Néstor Rodríguez-Chitiva, Javier Paúl-Martínez, Fredzzia Graterol Torres, Jordi Bover, Jordi Ara, Abhilash Koratala, Eduardo R. Argaiz, Faeq Husain-Syed, Gregorio Romero-González -
Corrigendum to “Tolerogenic dendritic cells protect against acute kidney injury.” Kidney International 2023;104:492–507 Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Jennifer S.Y. Li, Harry Robertson, Katie Trinh, Arti M. Raghubar, Quan Nguyen, Nicholas Matigian, Ellis Patrick, Angus W. Thomson, Andrew J. Mallett, Natasha M. Rogers -
PCSK6-associated membranous nephropathy in an adolescent with Sjögren disease Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Christian Hanna, Matthew L. Basiaga, Justin T. Kastl, Tiffany N. Caza, Sanjeev Sethi, Samih H. Nasr -
Clarifying the interpretation of semaglutide’s impact in the FLOW study Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Maxime Ingwiller -
Fibroblast growth factor (FGF) 23 and FGF receptor 4 induced cardiac mitochondrial dysfunction as a new target in CKD? Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Dieter Haffner, Maren Leifheit-NestlerChronic kidney disease is associated with excessive cardiovascular mortality, which is promoted by the phosphaturic hormone fibroblast growth factor 23 (FGF23). Increased FGF23 levels result in left ventricular hypertrophy via activation of the FGF receptor 4 activation. Fuchs et al. now demonstrate, using bioengineered cardiobundles, neonatal rat ventricular myocytes, and mice with chronic kidney
-
Glomerular deposits of neuron-derived neurotrophic factor in a case of membranous nephropathy lacking syphilis signature Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Rayane Benyahia, Serigne Gueye, Magali Colombat, Dominique Chauveau -
Clarifying criteria for complement-mediated TMA in patients without CFH antibodies or complement variants identified Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Alice Doreille, Laurent Mesnard -
Executive summary of the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Jürgen Floege, Keisha L. Gibson, Marina Vivarelli, Adrian Liew, Jai Radhakrishnan, Ethan M. Balk, Craig E. Gordon, Gaelen Adam, Marcello Tonelli, Amy Earley, Brad H. RovinThe Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Management of Glomerular Diseases was last updated and published in 2021. KDIGO continues to be committed to the nephrology community to provide periodic updates, based on new developments for each of the glomerular diseases. For children with nephrotic syndrome, the updated guideline now contains a treatment
-
Kidney organoids: a 3-dimensional tool to unmask permeability factors in primary and recurrent FSGS Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Federica Casiraghi, Giuseppe RemuzziPrimary focal segmental glomerulosclerosis is a glomerular disorder associated with a high risk of recurrence after transplantation. Compelling evidence supports the existence of circulating permeability factors whose identity remains elusive. In the current issue of Kidney International, Gupta et al. propose that kidney organoid can respond to these factors in patients with focal segmental glomerulosclerosis
-
Lupus nephritis treat to target normalizing anti-dsDNA, C3, and C4 is a bridge too far Kidney Int. (IF 14.8) Pub Date : 2025-04-18
H. Michael Belmont -
Simply measuring what matters—toward clinical utility of donor-derived cell-free DNA testing? Kidney Int. (IF 14.8) Pub Date : 2025-04-18
Maarten Naesens, Germaine Wong